Imagine having tiny electronics implanted somewhere in your body that can regulate nerve signals and make symptoms of various disorders go away.
That’s the vision of the field of bioelectronic medicine — the emerging discipline that has made enough promising advances to draw a big investment by a pharmaceutical giant, according to an article in Chemical & Engineering News(C&EN), the weekly news magazine of the American Chemical Society.
Ann M. Thayer, a senior correspondent at C&EN, explains that much of the progress made in bioelectronic medicine has been driven by university research so far. But more than a year ago, the British drug company GlaxoSmithKline dove into the field and is now funding about 25 investigations exploring disease biology and neural signaling. They are betting that the budding discipline will lead to a whole new class of medicines for metabolic, immune-inflammatory, respiratory, cardiovascular and other disorders.
Others are also heavily invested in the future of bioelectronic science. A few start-ups are working toward clinical applications. The National Institutes of Health is also advancing neuroscience with its Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. But scientists still have to work out some major puzzles before they can benefit patients. For one, they have to completely map out which nerves affect which organs and functions. Once that base is built, the field could be well poised to take off.
The Latest on: Bioelectronics
via Google News
The Latest on: Bioelectronics
- Bioelectronics Market 2022 Global Industry Analysis, Size, Share, Trends, and Forecast 2030 | Siemens AG,Avago,Abbott laboratories,Sotera wirelesson August 4, 2022 at 4:30 am
The main objective of this Bioelectronics Market research analysis is to discover the right opportunities, provide the right investment options and evaluate some actions to be taken for business ...
- Smart Mask Monitors Coughs to Identify Diseaseon August 3, 2022 at 11:30 am
Soft bioelectronics utilizing breathable and stretchable antennas can monitor the wearer’s physiological status.
- BioElectronics’ Chairman Discusses Recent Clinical Research Findingson July 22, 2022 at 3:03 am
FREDERICK, MD, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – BioElectronics Corporation (https://www.bielcorp.com/ OTC: BIEL a developer of medical ...
- BioElectronics’ Chairman Discusses Recent Clinical Research Findingson July 22, 2022 at 3:03 am
BioElectronics Corporation ( OTC: BIEL a developer of medical technology products, today announced via a Shareholder’s update that the Company has completed and undertaken additional clinical ...
- BioElectronics' Chairman Discusses Recent Clinical Research Findingson July 21, 2022 at 11:00 pm
The MarketWatch News Department was not involved in the creation of this content. FREDERICK, MD, Jul 22, 2022 (GLOBE NEWSWIRE via COMTEX) -- Company Receives Initial Purchase Order From Stada MENA ...
- Bioelectronics Market To Grow at High Pace in Upcoming Yearson July 11, 2022 at 10:10 am
As per the study, Bioelectronics Market regional landscape is bifurcated into 𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚, 𝐄𝐮𝐫𝐨𝐩𝐞, 𝐀𝐬𝐢𝐚 ...
via Bing News